Countagen
Out-of-the-box gene editing analysis
- CEO: Felix Neumann
- First investment year: 2022
- Fund: Stockholm
- Business sector: Life Science

Countagen offers simple-to-use consumable reagent kits that allow users to analyze gene editing efficiency and specificity with the same high precision as high-end instrumentation, but in a much more affordable way. It reliably counts and identifies gene edits with high accuracy using only basic laboratory equipment.